These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 39092646)

  • 1. Drug Delivery Systems for Natural Medicines in Cancer Therapy.
    Hashim PK; Punnoth Poonkuzhi N; Madappuram Cheruthu N; Saher Kuruniyan M
    Curr Top Med Chem; 2024 Jul; ():. PubMed ID: 39092646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Micelles as potential drug delivery systems for colorectal cancer treatment.
    Fatfat Z; Fatfat M; Gali-Muhtasib H
    World J Gastroenterol; 2022 Jul; 28(25):2867-2880. PubMed ID: 35978871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Applications of Nanotechnology-mediated Herbal Nanosystems for Ophthalmic Drug.
    Shree D; Patra CN; Sahoo BM
    Pharm Nanotechnol; 2024; 12(3):229-250. PubMed ID: 37587812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetic studies of nanoparticles as a delivery system for conventional drugs and herb-derived compounds for cancer therapy: a systematic review.
    Abdifetah O; Na-Bangchang K
    Int J Nanomedicine; 2019; 14():5659-5677. PubMed ID: 31632004
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nano-delivery systems for food bioactive compounds in cancer: prevention, therapy, and clinical applications.
    Vieira IRS; Conte-Junior CA
    Crit Rev Food Sci Nutr; 2024; 64(2):381-406. PubMed ID: 35938315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nano-Drug Delivery Systems Entrapping Natural Bioactive Compounds for Cancer: Recent Progress and Future Challenges.
    Chavda VP; Patel AB; Mistry KJ; Suthar SF; Wu ZX; Chen ZS; Hou K
    Front Oncol; 2022; 12():867655. PubMed ID: 35425710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug Delivery Systems Based on Polymeric Micelles and Ultrasound: A Review.
    Tanbour R; Martins AM; Pitt WG; Husseini GA
    Curr Pharm Des; 2016; 22(19):2796-807. PubMed ID: 26898742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid-based nanocarriers for enhanced delivery of plant-derived bioactive molecules: a comprehensive review.
    Kothapalli P; Vasanthan M
    Ther Deliv; 2024 Feb; 15(2):135-155. PubMed ID: 38214118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomacromolecule-based nanocarrier strategies to deliver plant-derived bioactive components for cancer treatment: A recent review.
    Gorain B; Karmakar V; Sarkar B; Dwivedi M; Leong JTL; Toh JH; Seah E; Ling KY; Chen KY; Choudhury H; Pandey M
    Int J Biol Macromol; 2023 Dec; 253(Pt 1):126623. PubMed ID: 37657573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming Skin Barrier with Transfersomes: Opportunities, Challenges, and Applications.
    Dixena B; Madhariya R; Panday A; Ram A; Jain AK
    Curr Drug Deliv; 2024 Jan; ():. PubMed ID: 38178667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nano-based targeted drug delivery for lung cancer: therapeutic avenues and challenges.
    Ezhilarasan D; Lakshmi T; Mallineni SK
    Nanomedicine (Lond); 2022 Oct; 17(24):1855-1869. PubMed ID: 35311343
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycaprolactone-based Nanocarriers Containing 5-fluorouracil as a Therapeutic Guided Drug Delivery Approach for Enhancing Anticancer Activity.
    Mohammadian S; Khazaei M; Maghami P; Avan A; Rezaei M
    Curr Cancer Drug Targets; 2023; 23(7):524-533. PubMed ID: 36809944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quercetin-based Nanoformulation: A Potential Approach for Cancer Treatment.
    Shivani ; Singh G; Narwal S; Chopra B; Dhingra AK
    Anticancer Agents Med Chem; 2023; 23(18):1983-2007. PubMed ID: 37592797
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herbal nanomedicines: Recent advancements, challenges, opportunities and regulatory overview.
    Teja PK; Mithiya J; Kate AS; Bairwa K; Chauthe SK
    Phytomedicine; 2022 Feb; 96():153890. PubMed ID: 35026510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary Formulations for Drug Delivery of Anticancer Bioactive Compounds.
    Ackova DG; Smilkov K; Bosnakovski D
    Recent Pat Anticancer Drug Discov; 2019; 14(1):19-31. PubMed ID: 30636616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Promising Nanomedicines of Shikonin for Cancer Therapy.
    Yan C; Li Q; Sun Q; Yang L; Liu X; Zhao Y; Shi M; Li X; Luo K
    Int J Nanomedicine; 2023; 18():1195-1218. PubMed ID: 36926681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advancements in the targeted delivery of etoposide nanomedicine for cancer therapy: A comprehensive review.
    Fathi-Karkan S; Arshad R; Rahdar A; Ramezani A; Behzadmehr R; Ghotekar S; Pandey S
    Eur J Med Chem; 2023 Nov; 259():115676. PubMed ID: 37499287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioavailability enhancers of herbal origin: an overview.
    Kesarwani K; Gupta R; Mukerjee A
    Asian Pac J Trop Biomed; 2013 Apr; 3(4):253-66. PubMed ID: 23620848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating natural compounds and nanoparticle-based drug delivery systems: A novel strategy for enhanced efficacy and selectivity in cancer therapy.
    Manzari-Tavakoli A; Babajani A; Tavakoli MM; Safaeinejad F; Jafari A
    Cancer Med; 2024 Mar; 13(5):e7010. PubMed ID: 38491817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.